Stay updated on Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and update link references; upgraded version to v3.2.0. - Removed the term “Differentiated thyroid carcinoma.”
    Difference
    2%
    Check dated 2025-10-06T16:04:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes the topic term 'Ovarian cancer' from the content, signaling a scope/content update with versioned revision rather than a data-heavy update.
    Difference
    0.1%
    Check dated 2025-09-29T09:57:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Updated the page version to v3.0.2 and removed the 'Back to Top' element; no core content, pricing, stock, or time-sensitive information changes detected.
    Difference
    0.1%
    Check dated 2025-09-15T00:16:15.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T20:49:30.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as new resources related to various cancers. Notably, the page now includes updated information on genetic and rare diseases, and specific studies related to cancer treatments.
    Difference
    9%
    Check dated 2025-08-31T12:58:28.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The study has been updated to reflect a new focus on the combination of Cabozantinib and Atezolizumab, with revised timelines and safety assessment parameters, while the previous status and some details have been removed.
    Difference
    3%
    Check dated 2025-08-24T09:33:05.000Z thumbnail image

Stay in the know with updates to Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.